Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial
With the aim of describing the long-term follow-up and to define the prognostic role of the clinical/pathological/molecular characteristics at diagnosis for childhood, adolescent and young adults affected by anaplastic large cell lymphoma (ALCL), we analyzed 420 patients aged up to 22 years homogene...
Main Authors: | Lara Mussolin, Marié-Cecilé Le Deley, Elisa Carraro, Christine Damm-Welk, Andishe Attarbaschi, Denise Williams, Amos Burke, Keizo Horibe, Atsuko Nakazawa, Grazyna Wrobel, Georg Mann, Monika Csóka, Anne Uyttebroeck, Rafael Fernández-Delgado Cerdá, Auke Beishuizen, Karin Mellgren, Birgit Burkhardt, Wolfram Klapper, Suzanne D. Turner, Emanuele S.G. d’Amore, Laurence Lamant, Alfred Reiter, Wilhelm Woessmann, Laurence Brugières, Marta Pillon, on behalf of the European Inter-Group for Childhood Non-Hodgkin lymphoma (EICNHL) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2747 |
Similar Items
-
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BI-ALCL)
by: R. Sabetta, et al.
Published: (2020-03-01) -
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL
by: Benedetto Longo, et al.
Published: (2022-12-01) -
The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
by: Ivonne A. Montes-Mojarro, et al.
Published: (2018-04-01) -
Breast lymphomas, breast implants and capsules The timeline of BIA-ALCL with respect to surgical consent: the UK perspective
by: Keith Allison, et al.
Published: (2022-12-01) -
ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa
by: Alexander Craig, et al.
Published: (2023-04-01)